|
| CIVIL DOCKET |
| UPDATED CIVIL DOCKET |
| Summons Issued with Magistrate Consent Notice attached as to Apotex Corp. on 12/28/2016; Apotex, Inc. on 12/28/2016. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (jcs) (Entered: 12/28/2016) |
| COMPLAINT filed against Apotex Corp., Apotex, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2054758.) - filed by Sanofi-Aventis U.S. LLC, Aventisub LLC, Sanofi, Genzyme Corporation. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(jcs) (Entered: 12/28/2016) |
| AFFIDAVIT of Service for Declaration of Mailing Pursuant to 10 Del. C. 3104 served on Apotex, Inc. on 12/29/2016, filed by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Bove, Jeffrey) (Entered: 12/29/2016) |
| Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jcs) (Entered: 12/28/2016) |
| Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: November 18, 2016. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 5/18/2019. (jcs) (Entered: 12/28/2016) |
| Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 6,794,410 C1; US 9,186,346 B2. (jcs) (Entered: 12/28/2016) |
| Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Sanofi for Aventisub LLC, Genzyme Corporation, Sanofi-Aventis U.S. LLC filed by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC. (Bove, Jeffrey) (Entered: 12/28/2016) |
| SUMMONS Returned Executed by Sanofi-Aventis U.S. LLC, Aventisub LLC, Sanofi, Genzyme Corporation. Apotex, Inc. served on 12/28/2016, answer due 1/18/2017. (Bove, Jeffrey) (Entered: 12/29/2016) |
| SUMMONS Returned Executed by Sanofi-Aventis U.S. LLC, Aventisub LLC, Sanofi, Genzyme Corporation. Apotex Corp. served on 12/28/2016, answer due 1/18/2017. (Bove, Jeffrey) (Entered: 12/29/2016) |
| STIPULATION TO EXTEND TIME to Answer, Move or Otherwise Respond to Complaint to February 10, 2017 - filed by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC. (Bove, Jeffrey) (Entered: 01/16/2017) |
| NOTICE of Appearance by John C. Phillips, Jr on behalf of Apotex Corp., Apotex, Inc. (Phillips, John) (Entered: 01/18/2017) |
| NOTICE of Appearance by David A. Bilson on behalf of Apotex Corp., Apotex, Inc. (Bilson, David) (Entered: 01/18/2017) |
| Amended Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 11/18/2016. Date of Expiration of Patent: SEE ATTACHED.Thirty Month Stay Deadline: 3/12/2020. (Bove, Jeffrey) (Entered: 01/20/2017) |
| STIPULATION TO EXTEND TIME to Answer, Move or Otherwise Respond to Complaint to March 10, 2017 - filed by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC. (Bove, Jeffrey) (Entered: 02/07/2017) |
| MOTION for Pro Hac Vice Appearance of Attorney Paul H. Berghoff, Alison J. Baldwin, Paula S. Fritsch, Ann C. Palma, and Brandon J. Kennedy - filed by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC. (Bove, Jeffrey) (Entered: 02/21/2017) |
| STIPULATION TO EXTEND TIME to Answer, Move or Otherwise Respond to Complaint to April 10, 2017 - filed by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC. (Bove, Jeffrey) (Entered: 03/10/2017) |
| STIPULATION TO EXTEND TIME to Move, Answer or Otherwise Respond to the Complaint to May 1, 2017 - filed by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC. (Bove, Jeffrey) (Entered: 04/10/2017) |
| ORDER REGARDING CASE MANAGEMENT IN CIVIL CASES. Signed by Judge Gregory M. Sleet on 4/20/2017. (asw) (Entered: 04/20/2017) |
| NOTICE of Voluntary Dismissal by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC as to Apotex, Inc. and Apotex Corp. (Bove, Jeffrey) (Entered: 04/28/2017) |
| Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s). (mdb) (Entered: 05/04/2017) |